Clinical Trial Update: Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated bevacizumab as maintenance therapy after induction in metastatic colorectal cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Colorectal Neoplasms | Phase 3 | Status: COMPLETED